DAVID GRELOTTI: Open Payments
NPI 1619003035 · BELMONT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 7 payments from 4 companies in 2025. Trend: 2023 $427 · 2024 $332 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $172 |
| Neurocrine BioSciences, Inc. | 1 | $157 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Braeburn Inc. | 2 | $31 |
Products named: INGREZZA, Yeztugo, Auvelity, BRIXADI.
Industry payments across MA — which companies pay providers there.
